web analytics

Redwood Pharma carries out a rights issue with the aim of replacing the existing credit facility

On August 25, 2019, the Board of Directors of Redwood Pharma AB (publ) decided to carry out a rights issue of shares which, upon full subscription, will provide the company SEK 11.5 million before issue costs of approximately SEK 0.3 million. The reason for the issue is mainly to liquidate the remaining part of the convertible facility that has existed since 2018.
The Board of Directors of Redwood Pharma AB (publ) (“Redwood Pharma” or “the Company”), supported by authorization from the Annual General Meeting on May 7, 2019, has decided to issue shares with preferential rights for existing

Source: Redwood Pharma carries out a rights issue with the aim of replacing the existing credit facility

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.